NALT (nasal cavity-associated lymphoid tissue) in the rabbit

Veterinary Immunology and Immunopathology

Volumn 133, Issue 2-4, 2010, Pages 212-218

  Casteleyn, C ^a   Broos, A M C ^a   Simoens, P ^a   Van den Broeck, W ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Histology; Lymphoid tissue; Nasal cavity; Rabbit; Vaccine

Indexed keywords

ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; FEMALE; HISTOLOGY; HUMAN VERSUS ANIMAL COMPARISON; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOSTIMULATION; LAMINA PROPRIA; LYMPH FOLLICLE; LYMPHOCYTE; LYMPHOID TISSUE; MUCOSAL IMMUNITY; NASAL CAVITY ASSOCIATED LYMPHOID TISSUE; NONHUMAN; NOSE CAVITY; RABBIT;

ANIMALS; FEMALE; HUMANS; LYMPHOID TISSUE; MODELS, ANIMAL; NASAL CAVITY; RABBITS; RODENTIA; SPECIES SPECIFICITY;

ANIMALIA; MAMMALIA; ORYCTOLAGUS CUNICULUS; RODENTIA;

EID: 72449153351     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2009.08.011     Document Type: Article

References (46)

1. Asakura K., Saito H., Hata M., and Kataura A. Antigen-specific IgA response of NALT and cervical lymph node cells in antigen-primed rats. Acta Otolaryngol. 118 (1998) 859-863
2. Asanuma H., Aizawa C., Kurata T., and Tamura S. IgA antibody-forming cell responses in the nasal-associated lymphoid tissue of mice vaccinated by intranasal, intravenous and/or subcutaneous administration. Vaccine 19 (1998) 1257-1262
3. Bergquist C., Johansson E.-L., Lagergård T., Holmgren J., and Rudin A. Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina. Infect. Immun. 65 (1997) 2676-2684
4. Boyaka P.N., Wright P.F., Marinaro M., Kiyono H., Johnson J.E., Gonzales R.A., Ikizler M.R., Werkhaven J.A., Jackson R.J., Fujihashi K., Di Fabio S., Staats H.F., and McGhee J.R. Human nasopharyngeal-associated lymphoreticular tissues. Functional analysis of subepithelial and intraepithelial B and T cells from adenoids and tonsils. Am. J. Pathol. 157 (2000) 2023-2035
5. Brandtzaeg P., and Pabst R. Let's go mucosal: communication on slippery ground. Trends Immunol. 25 (2004) 570-577
6. Casteleyn C.R., Van den Broeck W., and Simoens P. Histological characteristics and stereological volume assessment of the ovine tonsils. Vet. Immunol. Immunopathol. 120 (2007) 124-135
7. Cremaschi D., Ghirardelli R., and Porta C. Relationship between polypeptide transcytosis and lymphoid tissue in the rabbit nasal mucosa. Biochim. Biophys. Acta 1369 (1998) 287-294
8. Debertin A.S., Tschernig T., Tönjes H., Kleemann W.J., Tröger H.D., and Pabst R. Nasal-associated lymphoid tissue (NALT): frequency and localization in young children. Clin. Exp. Immunol. 134 (2003) 503-507
9. Debertin A.S., Tschernig T., Schürmann A., Bajanowski T., Brinkmann B., and Pabst R. Coincidence of different structures of mucosa-associated lymphoid tissue (MALT) in the respiratory tract of children: no indications for enhanced mucosal immunostimulation in sudden infant death syndrome (SIDS). Clin. Exp. Immunol. 146 (2006) 54-59
10. Di Tommaso A., Saletti G., Pizza M., Rappuoli R., Dougan G., Abrignani S., Douce G., and De Magistris M.T. Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant. Infect. Immun. 64 (1996) 974-979
11. Fujihashi K., Koga T., van Ginkel F.W., Hagiwara Y., and McGhee J.R. A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants. Vaccine 20 (2002) 2431-2438
12. Giannasca P.J., Boden J.A., and Monath T.P. Targeted delivery of antigen to hamster nasal lymphoid tissue with M-cell-directed lectins. Infect. Immun. 65 (1997) 4288-4298
13. Gizurarson S. Animal models for intranasal drug delivery studies: a review article. Acta Pharm. Nord. 2 (1990) 105-122
14. Gizurarson S., Bechgaard E., and Hjortkjaer R.K. Two intranasal administration techniques give two different pharmacokinetic results. Scand. J. Lab. Anim. Sci. 33 (2006) 35-38
15. Gooding H., and Stewart D. A comparative study of histological preparations of bone which have been treated with different combinations of fixatives and decalcifying fluids. Lab. J. 7 (1932) 55
16. Hameleers D.M.H., van der Ende M., Biewenga J., and Sminia T. An immunohistochemical study on the postnatal development of rat nasal-associated lymphoid tissue (NALT). Cell Tissue Res. 256 (1989) 431-438
17. Heritage P.L., Underdown B.J., Arsenault A.L., Snider D.P., and McDermott M.R. Comparison of murine nasal-associated lymphoid tissue and Peyer's patches. Am. J. Respir. Crit. Care Med. 156 (1997) 1256-1262
18. Hobson P., Barnfield C., Barnes A., and Klavinskis L.S. Mucosal immunization with DNA vaccines. Methods 31 (2003) 217-224
19. Hopkins S., Kraehenbuhl J.-P., Schödel F., Potts A., Peterson D., de Grandi P., and Nardelli-Haefliger D. A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization. Infect. Immun. 63 (1995) 3279-3286
20. Illum L. Nasal delivery. The use of animal models to predict performance in man. J. Drug Target. 3 (1996) 427-442
21. Jurcisek J.A., Durbin J.E., Kusewitt D.F., and Bakaletz L.O. Anatomy of the nasal cavity in the chinchilla. Cells Tissues Organs 174 (2003) 136-152
22. Kelemen G. The nasal and paranasal cavities of the rabbit in experimental work. Arch. Otolaryngol. 61 (1955) 497-512
23. Kiyono H., and Fukuyama S. NALT- versus Peyer's-patch-mediated mucosal immunity. Nat. Rev. Immunol. 4 (2004) 699-710
24. Koornstra P.J., De Jong F.I.C.R.S., Vlek L.F.M., Marres E.H.M.A., and van Breda Vriesman P.J.C. The Waldeyer ring equivalent in the rat. A model for analysis of oronasopharyngeal immune responses. Acta Otolaryngol. 111 (1991) 591-599
25. Kraal G. Nasal-assiociated lymphoid tissue. In: Mestecki J., Lamm M.E., Strober W., Bienenstock J., McGhee J.R., and Mayer L. (Eds). Mucosal Immunology. 3rd edition vol. 1 (2004), Elsevier, Academic Press, Amsterdam 415-422
26. Kuper C.F., Koornstra P.J., Hameleers D.M.H., Biewenga J., Spit B.J., Duijvestijn A.M., van Breda Vriesman P.J.C., and Sminia T. The role of nasopharyngeal lymphoid tissue. Immunol. Today 13 (1992) 219-224
27. Kuper C.F., Arts J.H.E., and Feron V.J. Toxicity to nasal-associated lymphoid tissue. Toxicol. Lett. 140-141 (2003) 281-285
28. Levine M.M. Can needle-free administration of vaccines become the norm in global immunization?. Nat. Med. 9 (2003) 99-103
29. Levine M.M., and Dougan G. Optimism over vaccines administered via mucosal surfaces. Lancet 351 (1998) 1375-1376
30. Liang B., Hyland L., and Hou S. Nasal-associated tissue is a site of long-term virus-specific antibody production following respiratory virus infection of mice. J. Virol. 75 (2001) 5416-5420
31. Liebler-Tenorio E.M., and Pabst R. MALT structure and function in farm animals. Vet. Res. 37 (2006) 257-280
32. Anonymous, 2005. Nomina Anatomica Veterinaria, 5th edition. World Association of Veterinary Anatomists, Hamburg, Columbia, Ghent, Sapporo. Internet reference: http://www.wava-amav.org. Accessed 29 May 2009.
33. Ogra P.L. Mucosal immune response in the ear, nose and throat. Pediatr. Infect. Dis. J. 19 (2000) S4-S8
34. Okada S., Ohtsuka A., Akagi H., Nishizake K., and Masuda Y. Blood microvascular organization of the nasal-associated lymphoid tissue of the guinea pig: a scanning electron microscopic study of corrosion casts. Acta Med. Okayama 49 (1995) 213-219
35. Oláh I., Nagy N., Magyar A., and Palya V. Esophageal tonsil: a novel gut-associated lymphoid organ. Poult. Sci. 82 (2003) 767-770
36. Partidos C.D. Intranasal vaccines: forthcoming challenges. Pharm. Sci. Technol. Today 3 (2000) 273-281
37. Renauld-Mongénie G., Mielcarek N., Cornette J., Schacht A.-M., Capron A., Riveau G., and Locht C. Induction of mucosal immune responses against a heterologous antigen fused to filamentous hemagglutinin after intranasal immunization with recombinant Bordetella pertussis. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 7944-7949
38. Rudin A., Riise G.C., and Holmgren J. Antibody responses in the lower respiratory tract and male urogenital tract in humans after nasal and oral vaccination with cholera toxin B subunit. Infect. Immun. 67 (1999) 2884-2890
39. Russell M.W., Moldoveanu Z., White P.L., Sibert G.J., Mestecky J., and Michalek S.M. Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the cholera toxin B subunit. Infect. Immun. 64 (1996) 1272-1283
40. Spit B.J., Hendriksen E.G.J., Bruijntjes J.P., and Kuper C.F. Nasal lymphoid tissue in the rat. Cell Tissue Res. 255 (1989) 193-198
41. Wu H.-Y., and Russell M.W. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect. Immun. 61 (1993) 314-322
42. Wu H.-Y., and Russell M.W. Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system. Immunol. Res. 16 (1997) 187-201
43. Wu H.-Y., Nikolova E.B., Beagley K.W., and Russell M.W. Induction of antibody-secreting cells and T-helper and memory cells in murine nasal lymphoid tissue. BMC Immunol. 88 (1996) 493-500
44. Wu H.-Y., Nguyen H.H., and Russell M.W. Nasal lymphoid tissue (NALT) as a mucosal immune inductive site. Scand. J. Immunol. 46 (1997) 506-513
45. Yamamoto S., Kiyono H., Yamamoto M., Imaoka K., Yamamoto M., Fujihashi K., Van Ginkel F.W., Noda M., Takeda Y., and McGhee J.R. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 5267-5272
46. Zuercher A.W. Upper respiratory tract immunity. Viral Immunol. 16 (2003) 279-289